Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Integrated PET/CT slightly improved restaging accuracy of breast cancer over PET
February 23rd, 2006
Integrated positron emission tomography (PET)/computed tomography (CT) slightly improved breast cancer restaging accuracy over 2-deoxy-2[F-18]fluoro-D-glucose (FDG) PET. "This study was conducted to compare the clinical stage derived from FDG PET to that of integrated PET/CT in restaged breast cancer patients. Fifty-eight female patients (age range 29-80 years, mean age ±SD, 53.3±11.7 years) underwent PET/CT restaging for breast cancer," researchers in the United States reported. "Two experienced nuclear medicine physicians interpreted PET images. A radiologist was added for reading PET/CT studies. A patient-based analysis was...
Source: Women's Health Weekly (2006-02-23)
|
